References

1. Rajagopal MR, Nandini V, Mathews L, KC R, Watson M. An Indian Primer of Palliative Care. Thiruvananthapuram, Kerala, India: Pallium India. 2017.
2. World Health Organization. WHO Definition of Palliative Care.Accessed 6 April 2015 at http://www.int/cancer/palliative/definition.
3. Rachow A, Ivanova O, Wallis R, Charalambous S, Jani I, Bhatt N, Kampmann B, Sutherland J, Ntinginya NE, Evans D, Lönnroth K. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB–a study protocol. BMC pulmonary medicine. 2019 Dec;19:1-9.
4. Forman WB, editor. Hospice and palliative care: Concepts and practice. Jones & Bartlett Learning; 2003.
5. Rai DK, Sharma P. Palliative care in drug resistance tuberculosis: an overlooked component in management. Indian Journal of Palliative Care. 2023 Oct;29(4):388.
6. Connor SR. Palliative care for tuberculosis. Journal of pain and symptom management. 2018 Feb 1;55(2):S178-80. 
7. Ashutosh N. Aggarwal, J ClinTuberc Other Mycobact Dis 17 (2019) 100121)
8. Molassiotis A, Bryan G, Caress A, et al. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature. Respir Med 2010; 104:934.
9. Schildmann EK, Rémi C, Bausewein C. Levodropropizine in the management of cough associated with cancer or nonmalignant chronic disease--a systematic review. J Pain Palliat Care Pharmacother 2011; 25:209.
10. Aliprandi P, Castelli C, Bernorio S, et al. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents. Drugs ExpClin Res 2004; 30:133
11. Matthys H, Bleicher B, Bleicher U. Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J Int Med Res 1983; 11:92
12. Slaton RM, Thomas RH, Mbathi JW. Evidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma. Ann Pharmacother 2013; 47:578
13. Doona M, Walsh D. Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med 1998; 12:55.
14. Dong R, Xu X, Yu L, et al. Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough. Aliment PharmacolTher 2019; 49:714
15. Hankerson MJ, Raffetto B, Mallon WK, Shoenberger JM.Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis. J Palliat Med 2015; 18:1060.
16. Komura S, Rodriguez RM, Peabody CR. Hemoptysis? Try Inhaled Tranexamic Acid. Emerg Med 2018; 54:e97
17. Mücke M, Mochamat, Cuhls H, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015; CD006788.
18. Preston NJ, Hurlow A, Brine J, Bennett MI. Blood transfusions for anaemia in patients with advanced cancer. Cochrane Database Syst Rev 2012;CD009007.
19. Hardy JR, Rees E, Ling J, et al. A prospective survey of the use of dexamethasone on a palliative care unit.Palliat Med 2001; 15:
20. Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and co-morbidities : treatment challenges in patients with comorbid diabetes mellitus and depression. Therapeutic Advances in Infectious Disease. 2022 May;9:20499361221095831.
21. Bates M, Marais BJ, Zumla A. Tuberculosis comorbidity with communicable and noncommunicable diseases. Cold Spring Harbor perspectives in medicine. 2015 Nov 1;5(11):a017889.
22. WHO, Global TB report 2021.TB and diabetes (who.int)
23.  https://tbcindia.gov.in/index1.php?lang=1&level=2&sublinkid=4179&lid= 2828
24.  Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI, Yu MC. The influence of diabetes, glycemic control, and diabetes-related co-morbidities  on pulmonary tuberculosis. PloS one. 2015 Mar 30;10(3):e0121698.
25.  WHO Tuberculosis and HIV. Global HIV Programme (who.int)
26. National AIDS Control Organization (2021). National Guidelines for HIV Care and Treatment, 2021. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India.
27. Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, Ormerod P, Ostermann M, Snelson C. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010 Jun 1;65(6):559-70.
28. Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. Journal of clinical and experimental hepatology. 2012 Sep 1;2(3):260-70.
29. Myers B, Bouton TC, Ragan EJ, White LF, McIlleron H, Theron D, Parry CD, Horsburgh CR, Warren RM, Jacobson KR. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC infectious diseases. 2018 Dec;18:1-9.
30. Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, Balakrishnan S, Subramoniapillai J, Oeltmann JE, Moonan PK, Kumar AM. Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India. Annals of the American Thoracic Society. 2014 Jun;11(5):712-8.
31. Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, Furin JJ, Shin SS. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. The International journal of tuberculosis and lung disease. 2012 Jul 1;16(7):891-6.
32. Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM: An International Journal of Medicine. 2010 Jul 1;103(7):461-87.
33. Shu CC, Liao KM, Chen YC, Wang JJ, Ho CH. The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse. Scientific reports. 2019 Aug 15;9(1):11901.
34. Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. European Respiratory Journal. 2017 Aug 1;50(2).
35. Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V, Löfdahl CG, Egesten A. COPD and the risk of tuberculosis-a population-based cohort study. PloS one. 2010 Apr 13;5(4):e10138
36. Ronan F.O'Toole RF, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease. Tuberculosis. 2015 Dec 1;95(6):659-63.
37. National Frame work for Joint TB-Tobacco :: Central TB Division (tbcindia.gov.in)
38. Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition& tuberculosis in India: Situation analysis & the way forward. Indian Journal of Medical Research. 2016 Jul 1;144(1):11-20.
39. Tadesse F, Mitiku H, Girma S, Kenay A. Magnitude of undernutrition and associated factors among adult tuberculosis patients attending public health facilities in Haramaya District, Eastern Ethiopia. BMC Pulmonary Medicine. 2023 Jan 30;23(1):42.
40. Guidance Document- Nutritional care and support for patients with tuberculosis in India (2017).
41. "Providing Care and Comfort at the End of Life". National Institute on Aging. Retrieved 2021-03-31.
42. https://www.ncbi.nlm.nih.gov/books/NBK247403/
43. Mani RK, Bhatnagar S, Butola S, Gursahani R, Mehta D, Simha S, Divatia JV, Kumar A, Iyer SK,  Deodhar J, Bhat RS. Indian Society of Critical Care Medicine and Indian Association of Palliative Care Expert Consensus and Position Statements for End-of-life and Palliative Care in the Intensive Care Unit. Indian Journal of Critical Care Medicine. 2024 Feb 29;28(3):200-50.
44. Fardy, H. Oxygen therapy in palliative care. npj Prim Care Resp Med26, 15073 (2016).https://doi.org/10.1038/npjpcrm.2015.73
45. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American journal of respiratory and critical care medicine. 2013 Oct 15;188(8):e13-64.
46. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, ZuWallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007 May 1;131(5):4S-2S.
47. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD. British Thoracic Society guideline on pulmonary rehabilitation in adults. Pneumonia. 2018 Apr 1;31(2).
48. Mendes LP, Moraes KS, Hoffman M, Vieira DS, Ribeiro-Samora GA, Lage SM, Britto RR, Parreira VF. Effects of diaphragmatic breathing with and without pursed-lips breathing in subjects with COPD. Respiratory care. 2019 Feb 1;64(2):136-44.
49. Belli S, Prince I, Savio G, Paracchini E, Cattaneo D, Bianchi M, Masocco F, Bellanti MT, Balbi B. Airway clearance techniques: the right choice for the right patient. Frontiers in medicine. 2021 Feb 4;8:544826.
50. Zeng Y, Jiang F, Chen Y, Chen P, Cai S. Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. International journal of chronic obstructive pulmonary disease. 2018 Jun 26:2013-23.
51. Sahasrabudhe SD, Orme MW, Jones AV, Tillu G, Salvi SS, Singh SJ. Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework. BMJ Open Respiratory Research. 2021 Nov 1;8(1):e000966.
52. Samal J, Dehury RK. Role of families in tuberculosis care: A case study. Muller Journal of Medical Sciences and Research. 2016 Jul 1;7(2):150-2.
53. Nagarajan K, Kumarsamy K, Begum R, Panibatla V, Reddy R, Adepu R, Munjattu JF, Sellapan S, Arangba S, Goswami A, Swamickan R. A Dual Perspective of Psycho-Social Barriers and Challenges Experienced by Drug-Resistant TB Patients and Their Caregivers through the Course of Diagnosis and Treatment: Findings from a Qualitative Study in Bengaluru and Hyderabad Districts of South India. Antibiotics. 2022 Nov 10;11(11):1586.
54. Fana TE, Sotana L. Exploring the experiences of family caregivers with people with drug-resistant tuberculosis. Cogent Social Sciences. 2021 Jan 1;7(1):1906494.
55. Rai A, Srivastava S, Singh SK, Srivastava A. Study of awareness of caregivers about tuberculosis treatment and its compliance.
56. Ewing G, Grande G, National Association for Hospice at Home. Development of a Carer Support Needs Assessment Tool (CSNAT) for end-of-life care practice at home: a qualitative study. Palliative medicine. 2013 Mar;27(3):244-56
57. Aggarwal AN. Tuberculosis transmission at healthcare facilities in India. Lung India. 2009 Apr 1;26(2):33-4.
58. Kumar MG, Joseph B, Goud BR, Joseph M, Rajitha M. Risk of tuberculosis infection among healthcare workers in a tertiary care hospital in Bengaluru City. Indian Journal of Occupational and Environmental Medicine. 2019 May 1;23(2):83-9.
59. Seo HS, Kim H, Hwang SM, Hong SH, Lee IY. Predictors of job satisfaction and burnout among tuberculosis management nurses and physicians. Epidemiology and health. 2016;38.
60. Bhargava, Anurag&Bharti, Kulkarni&Kurpad, Anura&Bhargava, Madhavi&Rao, Raghuram&Parmar, Malik & Nair, Sreenivas&Darshini, Padmapriya&Lait, Mahendru&Yunus, Shariqua&Shibu, Balakrishnan. (2017). Guidance Document: Nutritional care and support for patients with Tuberculosis in India.
61. Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014. 13, Palliative and end-of-life care. Available from:https://www.ncbi.nlm.nih.gov/books/NBK247403/
62. Datta, S., Gilman, R. H., Montoya, R., Cruz, L. Q., Valencia, T., Huff, D., Saunders, M. J., & Evans, C. A. (2020). Quality of life, tuberculosis and treatment outcome; a case–control and nested cohort study. The European Respiratory Journal, 56(2). https://doi.org/10.1183/13993003.00495-2019